GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » Total Assets

CK Life Sciences International Holdings (HKSE:00775) Total Assets : HK$11,247 Mil (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings Total Assets?

CK Life Sciences International Holdings's Total Assets for the quarter that ended in Dec. 2023 was HK$11,247 Mil.

During the past 12 months, CK Life Sciences International Holdings's average Total Assets Growth Rate was 0.10% per year. During the past 3 years, the average Total Assets Growth Rate was -1.30% per year. During the past 5 years, the average Total Assets Growth Rate was 1.70% per year. During the past 10 years, the average Total Assets Growth Rate was 2.20% per year.

During the past 13 years, CK Life Sciences International Holdings's highest 3-Year average Total Assets Growth Rate was 119.30%. The lowest was -2.90%. And the median was 4.40%.

Total Assets is connected with ROA %. CK Life Sciences International Holdings's annualized ROA % for the quarter that ended in Dec. 2023 was -0.35%. Total Assets is also linked to Revenue through Asset Turnover. CK Life Sciences International Holdings's Asset Turnover for the quarter that ended in Dec. 2023 was 0.25.


CK Life Sciences International Holdings Total Assets Historical Data

The historical data trend for CK Life Sciences International Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Total Assets Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,714.59 11,977.67 11,731.02 11,266.76 11,247.41

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,731.02 11,395.70 11,266.76 11,049.28 11,247.41

CK Life Sciences International Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

CK Life Sciences International Holdings's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=4189.253+7058.157
=11,247

CK Life Sciences International Holdings's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=4189.253+7058.157
=11,247

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CK Life Sciences International Holdings  (HKSE:00775) Total Assets Explanation

Total Assets is connected with ROA %.

CK Life Sciences International Holdings's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-39.324/( (11049.28+11247.41)/ 2 )
=-39.324/11148.345
=-0.35 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

CK Life Sciences International Holdings's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=2743.605/( (11049.28+11247.41)/ 2 )
=2743.605/11148.345
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

CK Life Sciences International Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (HKSE:00775) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines